Hudson Bay Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Hudson Bay Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.33M	Buy	+27,670	New	+$1.23M	0.01%	834
2025 Q3	–	Sell	-70,780	Closed	-$1.96M	–	1497
2025 Q2	$1.96M	Sell	70,780 -129,220	-65%	-$3.29M	0.01%	805
2025 Q1	$4.44M	Sell	200,000 -25,000	-11%	-$515K	0.03%	623
2024 Q4	$4.45M	Buy	225,000 +135,000	+150%	+$3.08M	0.03%	523
2024 Q3	$2.25M	Sell	90,000 -165,000	-65%	-$4.02M	0.02%	555
2024 Q2	$4.76M	Buy	255,000 +104,000	+69%	+$1.95M	0.04%	385
2024 Q1	$2.98M	Sell	151,000 -64,000	-30%	-$1.25M	0.03%	400
2023 Q4	$3.77M	Sell	215,000 -87,500	-29%	-$1.44M	0.03%	348
2023 Q3	$5.25M	Sell	302,500 -377,500	-56%	-$6.36M	0.05%	276
2023 Q2	$9.57M	Sell	680,000 -180,200	-21%	-$2.41M	0.1%	182
2023 Q1	$9.26M	Buy	860,200 +260,200	+43%	+$3.43M	0.1%	180
2022 Q4	$8.99M	Sell	600,000 -600,000	-50%	-$8.74M	0.1%	202
2022 Q3	$15.4M	Sell	1,200,000 -175,000	-13%	-$1.99M	0.16%	98
2022 Q2	$13.3M	Buy	1,375,000 +95,000	+7%	+$886K	0.13%	135
2022 Q1	$12.7M	Buy	1,280,000 +230,000	+22%	+$2.44M	0.18%	94
2021 Q4	$12.4M	Sell	1,050,000 -100,000	-9%	-$1.23M	0.14%	99
2021 Q3	$13.1M	Buy	1,150,000 +350,000	+44%	+$4.56M	0.18%	85
2021 Q2	$11.1M	Buy	800,000 +305,000	+62%	+$4.63M	0.14%	109
2021 Q1	$9.16M	Sell	495,000 -105,000	-18%	-$2.15M	0.13%	133
2020 Q4	$10.6M	Buy	600,000 +150,000	+33%	+$2.63M	0.14%	112
2020 Q3	$6.89M	Buy	450,000 +265,000	+143%	+$4.98M	0.12%	180
2020 Q2	$4.71M	Sell	185,000 -45,000	-20%	-$940K	0.09%	203
2020 Q1	$3.56M	Sell	230,000 -210,000	-48%	-$3.29M	0.09%	199
2019 Q4	$4.87M	Buy	440,000 +310,000	+238%	+$2.69M	0.12%	177
2019 Q3	$1.11M	Buy	130,000 +15,000	+13%	+$166K	0.03%	305
2019 Q2	$1.56M	Buy	115,000 +25,000	+28%	+$388K	0.04%	297
2019 Q1	$1.63M	Buy	+90,000	New	+$1.74M	0.05%	496